Literature DB >> 1716261

Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector.

F Libert1, M Ludgate, C Dinsart, G Vassart.   

Abstract

The sequential epitopes on the human thyroperoxidase (TPO) recognized by antibodies in the sera of patients with autoimmune thyroid disease were investigated using a recombinant DNA technique. Previous studies led to the isolation of two overlapping cDNA clones that encode polypeptides of TPO (85 residues, C2; 100 residues, C21) recognized by sera from several patients with autoimmune disease that contained antimicrosomal autoantibodies. In this report the vector pUEX1 was used to clone and express small random fragments of TPO cDNA in Escherichia coli as a beta-galactosidase fusion protein. Colonies were screened with a serum from a patient with Hashimoto's thyroiditis, and immunoreactive peptides were identified by sequencing the corresponding DNA inserts. Two linear epitopes of human TPO (amino acids 590-622 and 710-722) were recognized by the autoantibodies. This confirmed our previous results and provide a more precise localization of the antigenic determinants involved. The same approach has been applied in an attempt to identify the binding site(s) for autoantibodies on the human TSH receptor. In contrast to the data obtained with TPO, sera from patients with blocking (from idiopathic myxoedema) or stimulating (from Graves' disease) activity did not recognize the linear TSH receptor peptide fragments generated in our libraries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716261     DOI: 10.1210/jcem-73-4-857

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Relationship between autoantibody epitopic recognition and immunoglobulin gene usage.

Authors:  J Guo; R S Mcintosh; B Czarnocka; A P Weetman; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

Authors:  G Carayanniotis; G C Huang; L B Nicholson; T Scott; P Allain; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Rarity of autoantibodies to a major autoantigen, thyroid peroxidase, that interact with denatured antigen or with epitopes outside the immunodominant region.

Authors:  J Guo; Y Wang; J C Jaume; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  Recognition by recombinant autoimmune thyroid disease-derived Fab fragments of a dominant conformational epitope on human thyroid peroxidase.

Authors:  S Portolano; G D Chazenbalk; P Seto; J S Hutchison; B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics.

Authors:  R Elisei; D Weightman; P Kendall-Taylor; G Vassart; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

6.  Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  T cell responses to synthetic TSH receptor peptides in Graves' disease.

Authors:  N Tandon; M A Freeman; A P Weetman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 8.  Thyroid Autoantibodies Display both "Original Antigenic Sin" and Epitope Spreading.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.